Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 3/20 | 0.42 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.34 |
| ▸ | CA4 known ✓ | P22748 | 1/20 | 0.30 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.41 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6544283 | 1.00 | CA1 (0.42) | CA1FOLH1BBOX1CA2GPR84 | |
| SCHEMBL11175488 | 1.00 | CA1 (0.42) | CA1FOLH1BBOX1CA2GPR84 | |
| SCHEMBL11175514 | 1.00 | CA1 (0.42) | CA1FOLH1BBOX1CA2GPR84 | |
| SCHEMBL29913566 | 0.96 | CA1 (0.39) | CA1FOLH1BBOX1CA2GPR84 | |
| Potassium Ion SCHEMBL11242145 | 0.96 | CA1 (0.39) | CA1FOLH1BBOX1CA2GPR84 | |
| Potassium Ion SCHEMBL30177587 | 0.96 | CA1 (0.39) | CA1FOLH1BBOX1CA2GPR84 | |
| Potassium Ion SCHEMBL11242121 | 0.96 | CA1 (0.39) | CA1FOLH1BBOX1CA2GPR84 | |
| SCHEMBL11175500 | 0.90 | TET2 (0.35) | FOLH1NFKB1BLM | |
| SCHEMBL169001 | 0.88 | CA1 (0.45) | CA1FOLH1BBOX1CA2GPR84 | |
| SCHEMBL22194082 | 0.88 | CA1 (0.45) | CA1FOLH1BBOX1CA2GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260068877-A1 | COMPOSITION | Aspire Technology Group Ltd (GB) | 2026-03-12 | — | — | US | claimed |
| US-20260068878-A1 | COMPOSITION | Aspire Technology Group Ltd (GB) | 2026-03-12 | — | — | US | claimed |
| US-12527327-B2 | High hyaluronate multi-purpose disinfection solutions for ophthalmic applications | CIS BIOPHARMA AG (CH) | 2026-01-20 | — | — | US | claimed |
| EP-4658230-A1 | PERSONAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2025-12-10 | — | — | EP | claimed |
| WO-2025132548-A1 | COMPOSITION FOR LIGHTENING KERATIN FIBERS AND PROCESS FOR LIGHTENING KERATIN FIBERS USING SAID COMPOSITION | L'OREAL (FR) | 2025-06-26 | — | — | WO | claimed |
| WO-2025091213-A1 | COMPOSITION FOR CONDITIONING THE HAIR | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| WO-2025091216-A1 | PROCESS FOR CONDITIONING THE HAIR | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| EP-4543400-A1 | METHOD FOR THE TREATMENT OF KERATIN FIBRES COMPRISING A PRETREATMENT OR POST-TREATMENT STEP | L'OREAL (FR) | 2025-04-30 | — | — | EP | claimed |
| WO-2025069043-A1 | SUSTAINABLE COMPOSITIONS AND METHODS FOR DYEING AND/OR LIGHTENING KERATIN FIBRES | L'OREAL (FR) | 2025-04-03 | — | — | WO | claimed |
| US-20250057745-A1 | USE OF A PARTICULAR CARBOXYLIC ACID OR SALTS THEREOF FOR REPAIRING AND/OR PREVENTING BREAKAGE OF KERATIN FIBRES | L'OREAL (FR) | 2025-02-20 | — | — | US | claimed |
| CN-117339992-B | Method for removing rare earth elements in polluted soil in situ based on magnetic material | 中国科学院广州地球化学研究所 | 2024-05-07 | — | — | CN | claimed |
| CN-117339992-A | Method for removing rare earth elements in polluted soil in situ based on magnetic material | 中国科学院广州地球化学研究所 | 2024-01-05 | — | — | CN | claimed |
| WO-2023247614-A1 | METHOD FOR THE TREATMENT OF KERATIN FIBRES COMPRISING A PRETREATMENT OR POST-TREATMENT STEP | L'OREAL (FR) | 2023-12-28 | — | — | WO | claimed |
| WO-2023111059-A1 | USE OF A PARTICULAR CARBOXYLIC ACID OR SALTS THEREOF FOR REPAIRING AND/OR PREVENTING BREAKAGE OF KERATIN FIBRES | L'OREAL (FR) | 2023-06-22 | — | — | WO | claimed |
| US-20230148604-A1 | HIGH HYALURONATE MULTI-PURPOSE DISINFECTION SOLUTIONS FOR OPHTHALMIC APPLICATIONS | CIS BIOPHARMA AG (CH) | 2023-05-18 | — | — | US | claimed |
| WO-2023062523-A1 | SANITIZING/CLEANING AND DISINFECTANT FORMULATION | 99 HOLDING S.A.R.L. (LU) | 2023-04-20 | — | — | WO | claimed |
| CN-115605185-A | Use of a chelating agent to prevent the formation of visible particles in parenteral protein solutions | 豪夫迈·罗氏有限公司（CH） | 2023-01-13 | — | — | CN | claimed |
| EP-4082652-A1 | ELECTRODIALYSIS DEVICE | MEIKO Maschinenbau GmbH & Co. KG (DE) | 2022-11-02 | — | — | EP | claimed |
| EP-2592134-B1 | Sustainable cleaning agents and detergents | COMPAD CONSULTING GMBH (CH) | 2022-11-02 | — | — | EP | claimed |
| EP-3878816-A1 | METHOD FOR PREPARING HIGH PURITY ALUMINUM MONOHYDRATE AND ALPHA ALUMINA | Almatis GmbH (DE) | 2021-09-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260068878-A1 | COMPOSITION | SCD, SORD, SCD5 | CA1 1115/4885CA2 610/4885CA4 785/4885 |
| US-12527327-B2 | High hyaluronate multi-purpose disinfection solutions for ophthalmic applications | CD44, HCN4, MUC1 | CA1 2875/4885CA2 1913/4885CA4 1965/4885 |
| US-20250057745-A1 | USE OF A PARTICULAR CARBOXYLIC ACID OR SALTS THEREOF FOR REPAIRING AND/OR PREVENTING BREAKAGE OF KERATIN FIBRES | KRT18, CUTA, DSG1 | CA1 100/4885CA2 61/4885CA4 127/4885 |
| US-20260068877-A1 | COMPOSITION | SCD, SORD, CD44 | CA1 1515/4885CA2 976/4885CA4 843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.